Article

Bayer Wins Early US Approval for Colon Cancer Drug

The U.S. Food and Drug Administration on Thursday approved a new drug for advanced colon cancer developed by Bayer AG, a month ahead of the agency's expected action date for a decision.

The drug, to be sold under the brand name Stivarga, was approved to treat colon cancer that has progressed after prior treatment or that has spread to other parts of the body, the agency said.

Read the full story: reut.rs/QyWLff

Source: Reuters

Related Videos
Debra Patt, MD, PhD, MBA, MPH
2 experts in this video
2 experts in this video
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Mikkael Sekeres, MD
Kim Newcomer, director of volunteers, Colorectal Cancer Alliance
Gladys Antelo-Allen
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo